Vaccine Distribution (Including Influenza)

The Wisconsin Vaccine Distribution multi-award vehicle is a comprehensive state-wide contract designed to facilitate the procurement of vaccines, immunological products, and related pharmaceutical agents. The contract covers a range of medical products including influenza vaccines, diphtheria and tetanus vaccines, immunomodulating drugs, and various specialized pharmaceutical compounds. Its primary purpose is to provide state and local government entities with streamlined access to critical vaccination and medical treatment resources, encompassing products categorized under specific UNSPSC and NIGP codes related to diagnostic agents, serums, toxoids, and vaccines.

The vehicle is administered by the Wisconsin Department of Administration and was awarded on August 28, 2020, with multiple prime contractors including pharmaceutical manufacturers such as Sanofi Pasteur, GlaxoSmithKline, Seqirus, and AstraZeneca. Distribution is managed through key vendors like Cardinal Health, AmerisourceBergen, McKesson Medical-Surgical, ASD Specialty Healthcare, and FFF Enterprises. The contract offers flexible pricing structures, with some vendors providing chargeback options and others utilizing fixed pricing models. While specific contract values are not disclosed, the multi-year agreements typically span 2-3 years with extension options, covering vaccine pre-booking, delivery schedules, and comprehensive distribution services across Wisconsin and potentially other participating states through the MMCAP Infuse consortium.